Deutsche Bank Analysts Give Evonik Industries (EVK) a €40.00 Price Target
Evonik Industries (FRA:EVK) received a €40.00 ($47.62) price objective from stock analysts at Deutsche Bank in a report issued on Friday. The brokerage presently has a “buy” rating on the stock. Deutsche Bank’s price objective would suggest a potential upside of 24.77% from the stock’s current price.
EVK has been the topic of several other research reports. Commerzbank set a €33.00 ($39.29) target price on Evonik Industries and gave the company a “buy” rating in a research report on Monday, September 18th. Kepler Capital Markets set a €31.00 ($36.90) target price on Evonik Industries and gave the company a “neutral” rating in a research report on Friday, November 3rd. Barclays set a €35.50 ($42.26) target price on Evonik Industries and gave the company a “buy” rating in a research report on Monday, November 6th. Baader Bank set a €38.00 ($45.24) target price on Evonik Industries and gave the company a “buy” rating in a research report on Thursday, December 14th. Finally, DZ Bank reaffirmed a “neutral” rating on shares of Evonik Industries in a research report on Monday, October 2nd. Two analysts have rated the stock with a sell rating, six have given a hold rating and eleven have issued a buy rating to the company. Evonik Industries has a consensus rating of “Hold” and an average target price of €33.75 ($40.18).
Shares of Evonik Industries (FRA:EVK) opened at €32.06 ($38.17) on Friday. The stock has a market capitalization of $14,850.00 and a price-to-earnings ratio of 20.42. Evonik Industries has a 52-week low of €26.78 ($31.88) and a 52-week high of €32.97 ($39.25).
About Evonik Industries
Evonik Industries AG engages in the specialty chemicals business worldwide. It operates through Nutrition & Care, Resource Efficiency, Performance Materials, and Services segments. The Nutrition & Care segment offers specialty chemicals, including amphoteric surfactants, ceramides, phytosphingosines, oleochemical quaternary derivatives, organically modified silicones, superabsorbents, amino acids and amino acid derivatives, synthesis products, pharmaceutical polymers, and DL-methionine for use in consumer goods, animal nutrition, and healthcare sectors.
Receive News & Ratings for Evonik Industries Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Evonik Industries and related companies with Analyst Ratings Network's FREE daily email newsletter.